Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03324464 · ClinicalTrials.gov registry record · NA
Central Executive Training (CET) for ADHD
A NA study of ADHD, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 251
- Enrollment target
- 1
- Study location
NCT03324464: Completed NA study of ADHD, sponsored by Florida State University.
NCT03324464 is a NA study of ADHD that has completed, run by Florida State University. The registered enrollment target is 251 participants, above the 187-participant average among 75 other ADHD trials with a reported enrollment target (34% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03324464, a NA study of ADHD, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 251 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the current project is to assess the efficacy of Central Executive Training (CET) for youth with ADHD. CET is a new, computerized training intervention that targets specific components of the working memory system. Two versions of CET were developed as part of our R34, each targeting a different combinations of executive functions. The final CET protocol reflects the contributions and feedback of a diverse group of caregivers, children with ADHD, and recognized experts in human cognition, ADHD treatment research, randomized control trial (RCT) intervention design methods, serious game theory and task design, cognitive training, and the role of executive dysfunction in ADHD.
Primary Outcome
Average of T-scores on parent-report ADHD symptoms questionnaires (Attention Deficit Hyperactivity Disorder Rating Scale (ADHD-5) Inattention and Hyperactivity subscales, Behavioral Assessment System for Children (BASC-3) Inattention and Hyperactivity subscales)
Conditions Studied
Interventions
- BEHAVIORAL Central Executive Training: Working Memory
- BEHAVIORAL Central Executive Training: Inhibitory Control
Study Locations (1)
Florida
- Florida State University - Tallahassee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2024-01-05 |
| Phase | NA |
What the finished NCT03324464 record still lists
NCT03324464 is an interventional study that assigns participants to a tested intervention. The registered 251 participants enrollment target is mid-sized for trials with a published cap, above the 187-participant average among 75 other ADHD trials with a reported enrollment target (34% higher).
The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 2 interventions - of which Central Executive Training: Working Memory is the first listed.
NCT03324464 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03324464 about?
NCT03324464 is a clinical study titled "Central Executive Training (CET) for ADHD". The goal of the current project is to assess the efficacy of Central Executive Training (CET) for youth with ADHD. CET is a new, computerized training intervention that targets specific components of the working memory system. Two versions of CET were developed as part of our R34, each targeting a d...
What is the current status of trial NCT03324464?
This trial is currently completed. It is a NA study. The enrollment target is 251 participants. The study started on 2018-01-01. Estimated completion is 2024-01-05.
What conditions does trial NCT03324464 study?
This clinical trial studies the following conditions: ADHD.
What interventions are being tested in trial NCT03324464?
The interventions under investigation include: Central Executive Training: Working Memory (BEHAVIORAL), Central Executive Training: Inhibitory Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT03324464?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03324464 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03324464's enrollment target sits among peer trials
251 16th of 75 higher than 60 of 75 other ADHD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Target ADHD Executive Working Memory Replication Study
RECRUITING · NA
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Fidgeting and Attentional and Emotional Regulation in ADHD
RECRUITING · NA
-
Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study
RECRUITING · NA
-
A Pilot Study of a Remote ADHD Monitoring Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06043817 · 251 participants · Phase 1
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI